LobbyingStimlabs lobbying by quarter
Stimlabs's latest lobbying report covers Q4 2025, at $30K. The four quarters Q4 2025–Q3 2026 total $30K. Its first report covers Q3 2024; the issues it reports most are Health Issues.
Stimlabs
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $30K
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q3 2024
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2024 | $30K | 1 |
| Q4 2024 | $30K | 1 |
| Q1 2025 | $30K | 1 |
| Q2 2025 | $30K | 1 |
| Q3 2025 | $30K | 1 |
| Q4 2025 | $30K | 1 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$180K · 6 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES4 reports
- SENATE4 reports
Firms it paid
| Firm | ||
|---|---|---|
| Hart Health Strategies | $180K | 6 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 01/16for Q4 2025 | Hart Health Strategies | $30K |
| 25/10/20for Q3 2025 | Hart Health Strategies | $30K |
| 25/07/10for Q2 2025 | Hart Health Strategies | $30K |
| 25/04/18for Q1 2025 | Hart Health Strategies | $30K |
| 25/01/05for Q4 2024 | Hart Health Strategies | $30K |
| 24/10/21for Q3 2024 | Hart Health Strategies | $30K |
| 24/10/10for Q2 2024 | Hart Health Strategies | Under $5,000 |